This webinar will cover the latest advancements in medication management for obesity, specifically for psychiatric practice. The speaker will review current pharmacological treatments, including newly approved medications, and their applications in managing obesity. Attendees will learn about the safety, efficacy, and psychiatric considerations when prescribing these medications. The session will also explore how to integrate these treatments into a comprehensive care plan addressing both physical and mental health. By the end, participants will be equipped with the latest knowledge to improve outcomes in obesity management for psychiatric patients.
Format
Recorded webinar
1.5 hours of virtual, synchronous learning.
Learning Objectives
- Review current pharmacological treatments for obesity and their specific applications in psychiatric practice.
- Understand the safety and efficacy profiles of newly approved obesity medications and their impact on psychiatric patients.
- Identify key psychiatric considerations when prescribing obesity medications, including potential side effects and interactions.
- Learn how to integrate obesity medications into comprehensive care plans that address both mental and physical health.
- Enhance clinical decision-making by applying the latest evidence-based knowledge in obesity medication management to optimize patient outcomes.
References
- Chakhtoura M, Haber R, Ghezzawi M, Rhayem C, Tcheroyan R, Mantzoros CS. Pharmacotherapy of obesity: an update on the available medications and drugs under investigation. EClinicalMedicine. 2023 Mar 20;58:101882. doi: 10.1016/j.eclinm.2023.101882. PMID: 36992862; PMCID: PMC10041469.
- Roomy MA, Hussain K, Behbehani HM, Abu-Farha J, Al-Harris R, Ambi AM, Abdalla MA, Al-Mulla F, Abu-Farha M, Abubaker J. Therapeutic advances in obesity management: an overview of the therapeutic interventions. Front Endocrinol (Lausanne). 2024 Apr 23;15:1364503. doi: 10.3389/fendo.2024.1364503. PMID: 38715796; PMCID: PMC11074390.
- Müller, T.D., Blüher, M., Tschöp, M.H. et al. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov 21, 201–223 (2022). https://doi.org/10.1038/s41573-021-00337-8
Target Audience
Medical students, Residents/Fellows, Psychiatrists, Non-psychiatrist physicians
Estimate Time to Complete
Estimated Duration: 1.5 hours
Program Start Date: December 6, 2024
Program End Date: December 6, 2027
Credit for this webinar must be claimed by December 6, 2027.
How to Earn Credit
After evaluating the program, participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the event date and hours earned.
Continuing Education Credit
In support of improving patient care, the American Psychiatric Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The APA designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Instructor
- Vikas Gupta, MD, MPH, DABOM, FAPA, Founder & CEO, Wellness Psychiatry P.C.
Planners
- Vikas Gupta, MD, MPH, DABOM, FAPA, Founder & CEO, Wellness Psychiatry P.C.
- Vishal Madaan, MD, APA Deputy Medical Director, Reports no financial relationships with commercial interests.
Accessibility for Participants with Disabilities
The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. Please contact the American Psychiatric Association at 202-559-3900, if you require assistance seven (7) business days prior to the start of a live webinar.
Technical Requirements
This internet-based CME activity is best experienced using any of the following:
- The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer 11+
This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration:
- Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
- Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
- Internet Connection: 1 Mbps or higher
Minimum Requirements:
- Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
- Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content
For assistance: Contact educme@psych.org for questions about this activity